Why the study?
The growing elderly population places a heavy burden on healthcare, requiring special knowledge to manage altered drug pharmacokinetics, complex clinical manifestations, and prevalent cardiovascular diseases.
Population
Adults over 65 years of age
Design
Review article
Authors
Loading...
Geriatric CVD care demands age-tailored vigilance; leaves open dedicated trials for optimal management in frail patients.
This review highlights the increasing prevalence, atypical clinical presentation, and specific management challenges of cardiovascular diseases such as coronary artery disease, hypertension, heart failure, and atrial fibrillation in the geriatric population.
Gadó et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: